Olympus Corporation, a global MedTech company, has announced a new collaboration with DuPont, a global name in materials science and sustainable innovation based in the United States, to introduce more environmentally responsible packaging solutions for Olympus’ single-use portfolio of endotherapeutic devices, which are used worldwide.
This initiative is enabled by DuPont Tyvek with Renewable Attribution, which Olympus will begin incorporating into the sterile packaging of over 100 single-use device categories, starting in 2026.
As part of its environmental, social, and governance (ESG) strategy, Olympus has designated “Carbon Neutral Society and Circular Economy” as a focal area and has committed to achieving a circular economy through product stewardship. Collaborating with DuPont, Olympus is further strengthening its dedication to environmentally responsible, sustainable healthcare.
As the first phase in this collaboration, Olympus will introduce medical device packaging utilizing DuPont Tyvek with Renewable Attribution at its manufacturing facilities in Japan and Vietnam, covering more than 100 single-use device categories, including sampling and therapeutic devices for GI and respiratory endoscopes.
Tyvek with Renewable Attribution uses a certified mass balance approach to integrate renewable feedstocks, reducing reliance on fossil fuels and the carbon footprint of healthcare packaging—without compromising performance or regulatory compliance.
This switch is expected to lower CO2 emissions by approximately one-third of the total carbon footprint of Tyvek. Olympus will expand the initiative gradually to additional manufacturing sites and product lines in subsequent phases. Through this packaging advancement, Olympus is accelerating its path toward carbon neutrality and meeting growing industry and regulatory expectations for environmentally conscious design.
